Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Harmony Biosciences Inc.

    NASDAQ: HRMY · Real-Time Price · USD
    32.94
    -0.03 (-0.09%)
    At close: Jun 16, 2025, 3:59 PM
    32.90
    -0.11%
    Pre-market: Jun 17, 2025, 06:24 AM EDT

    Harmony Biosciences Statistics

    Share Statistics

    Harmony Biosciences has 57.42M shares outstanding. The number of shares has increased by 0.97% in one year.

    Shares Outstanding

    n/a
    		 57.42M

    Shares Change (YoY)

    n/a
    		 0.97%

    Shares Change (QoQ)

    n/a
    		 0.55%

    Owned by Institutions (%)

    n/a
    		 92.7%

    Shares Floating

    n/a
    		 43.61M

    Failed to Deliver (FTD) Shares

    n/a
    		 854

    FTD / Avg. Volume

    n/a
    		 0.12%

    Short Selling Information

    The latest short interest is 3.38M, so 5.88% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.38M

    Short % of Shares Out

    n/a
    		 5.88%

    Short % of Float

    n/a
    		 12.91%

    Short Ratio (days to cover)

    n/a
    		 5.33

    Valuation Ratios

    The PE ratio is 13.45 and the forward PE ratio is 8.22. Harmony Biosciences's PEG ratio is 0.75.

    PE Ratio

    n/a
    		 13.45

    Forward PE

    n/a
    		 8.22

    PS Ratio

    n/a
    		 2.74

    Forward PS

    n/a
    		 1.1

    PB Ratio

    n/a
    		 2.97

    P/FCF Ratio

    n/a
    		 8.95

    PEG Ratio

    n/a
    		 0.75
    Financial Ratio History

    Enterprise Valuation

    Harmony Biosciences has an Enterprise Value (EV) of 1.68B.

    EV / Sales

    n/a
    		 2.36

    EV / EBITDA

    n/a
    		 7.21

    EV / EBIT

    n/a
    		 7.66

    EV / FCF

    n/a
    		 7.7

    Financial Position

    The company has a current ratio of 3.31, with a Debt / Equity ratio of 0.27.

    Current Ratio

    n/a
    		 3.31

    Quick Ratio

    n/a
    		 3.27

    Debt / Equity

    n/a
    		 0.27

    Debt / EBITDA

    n/a
    		 0.77

    Debt / FCF

    n/a
    		 0.82

    Interest Coverage

    n/a
    		 10.91

    Financial Efficiency

    Return on Equity is 22.07% and Return on Invested Capital is 17.22%.

    Return on Equity

    n/a
    		 22.07%

    Return on Assets

    n/a
    		 14.56%

    Return on Invested Capital

    n/a
    		 17.22%

    Revenue Per Employee

    n/a
    		 $2,666,917.91

    Profits Per Employee

    n/a
    		 $542,884.33

    Employee Count

    n/a
    		 268

    Asset Turnover

    n/a
    		 0.72

    Inventory Turnover

    n/a
    		 21.79

    Taxes

    Income Tax

    n/a
    		 46.31M

    Effective Tax Rate

    n/a
    		 24.14%

    Stock Price Statistics

    The stock price has increased by 12.16% in the last 52 weeks. The beta is 0.87, so Harmony Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.87

    52-Week Price Change

    n/a
    		 12.16%

    50-Day Moving Average

    n/a
    		 32.21

    200-Day Moving Average

    n/a
    		 34.61

    Relative Strength Index (RSI)

    n/a
    		 42.5

    Average Volume (20 Days)

    n/a
    		 719,749

    Income Statement

    In the last 12 months, Harmony Biosciences had revenue of 714.73M and earned 145.49M in profits. Earnings per share was 2.56.

    Revenue

    n/a
    		 714.73M

    Gross Profit

    n/a
    		 557.92M

    Operating Income

    n/a
    		 190.83M

    Net Income

    n/a
    		 145.49M

    EBITDA

    n/a
    		 233.41M

    EBIT

    n/a
    		 209.3M

    Earnings Per Share (EPS)

    n/a
    		 2.56
    Full Income Statement

    Balance Sheet

    The company has 453M in cash and 179.27M in debt, giving a net cash position of 273.74M.

    Cash & Cash Equivalents

    n/a
    		 453M

    Total Debt

    n/a
    		 179.27M

    Net Cash

    n/a
    		 273.74M

    Retained Earnings

    n/a
    		 2.22M

    Total Assets

    n/a
    		 1.06B

    Working Capital

    n/a
    		 467.57M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 219.82M and capital expenditures -1.15M, giving a free cash flow of 218.67M.

    Operating Cash Flow

    n/a
    		 219.82M

    Capital Expenditures

    n/a
    		 -1.15M

    Free Cash Flow

    n/a
    		 218.67M

    FCF Per Share

    n/a
    		 3.84
    Full Cash Flow Statement

    Margins

    Gross margin is 78.06%, with operating and profit margins of 26.7% and 20.36%.

    Gross Margin

    n/a
    		 78.06%

    Operating Margin

    n/a
    		 26.7%

    Pretax Margin

    n/a
    		 26.84%

    Profit Margin

    n/a
    		 20.36%

    EBITDA Margin

    n/a
    		 32.66%

    EBIT Margin

    n/a
    		 26.7%

    FCF Margin

    n/a
    		 30.59%

    Dividends & Yields

    HRMY does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 7.43%

    FCF Yield

    n/a
    		 11.17%
    Dividend Details

    Analyst Forecast

    The average price target for HRMY is $50, which is 51.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $50

    Price Target Difference

    n/a
    		 51.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 14
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 25.82

    Graham Upside

    n/a
    		 -21.62%

    Scores

    Altman Z-Score

    n/a
    		 5.41

    Piotroski F-Score

    n/a
    		 8

    Add to Watchlist